Observational studyScientific reports2025
Impact of a novel smartphone application for remote monitoring of gestational diabetes on glycaemic control and birth outcomes: a pilot observational study.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Continuous Glucose Monitoring in Gestational Diabetes Mellitus: Evidence, Clinical Benefits and Remaining Challenges.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
- Mobile Health Interventions in Gestational Diabetes Mellitus and Pregnancy Outcomes: A Scoping Review.Cureus · 2026Review
- Managing Gestational Diabetes Complexity with Continuous Glucose Monitoring: A Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- Acceptance of the Istel Care Telehealth System by Women with Gestational Diabetes (GDM) in Routine Care in Poland.Patient preference and adherence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The significance of increasing rates of gestational diabetes mellitus (GDM) is confronting healthcare systems. The advent of telemedicine provides an opportunity to alleviate this pressure. We sought to evaluate the impact of a tailored smartphone app-assisted care pathway ('GDMapp') designed for personalised self-management for patients with newly diagnosed GDM. Women with GDM, commencing a trial of medical nutrition and lifestyle therapy, were approached for consideration for enrolment. Glycaemic, maternal, perinatal, and neonatal outcomes were compared between the app-using group and matched historical controls. Data variables were summarised using univariable descriptive statistics. The groups were compared using statistical hypothesis testing. 'GDMapp' was used by 168 participants. Outcomes were measured against a historical control group of 162 prospectively recruited patients receiving standard GDM care. Patients using the app had lower overall glycaemic indices across both fasting (p = 0.022) and postprandial (p < 0.001) parameters. Overall, app-users had fewer instances of above threshold glycaemic control. Adjunctive use of app- based care demonstrated non-inferiority for adverse maternal, birth and neonatal outcomes. This app-assisted model of care for GDM safely facilitates self-management and remote monitoring of GDM. The improved postprandial glycaemic control among app-users reflects the benefit of the in-app educational, motivational, and self-management tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.